Shree Ganesh Remedies Limited (SGRL.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹655.95 (+4.05%) as of
Key statistics
- Market cap
- 8.42B
- P/E (TTM)
- 54.98
- EPS (TTM)
- 11.93
- Dividend yield
- 0.00%
- 52-week range
- 381.10 – 759.00
- Beta
- 0.51
- Revenue (TTM)
- 989.78M
- Profit margin
- 15.59%
- Volume
- 1.53k
About Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals. In addition, the company offers customized chemistry and manufacturing; assets and infrastructure; and customized processes of pharmaceutical chemicals. It also exports its products. The company serves life sciences, flavor and fragrance, polymer industries, electronics, and agro chemicals markets. Shree Ganesh Remedies Limited was incorporated in 1995 and is headquartered in Ankleshwar, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Ankleshwar, India
- Employees
- 224
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.